On Jun 29, 2021 Element Biosciences closed a Series C round and raised $276,000,000 from Counterpoint Global, Fidelity Management and Research Company, Foresite Capital, Janus Henderson Investors, JS Capital Management, Logos Capital, Meritech Capital Partners, RA Capital Management, T. Rowe Price, Venrock, featuring lead investors Venrock.
About the company: Element Biosciences is located in San Diego, United States, North America. “Our reimagined DNA sequencing platform allows scientists to transform their research from inquiry to insight to create tangible impact for the real world.
Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. Founded in 2017, our headquarters is located in San Diego, California, with additional operations located in the San Francisco Bay area.”
Company website: www.elementbiosciences.com/
